Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Izzy who wrote (4378)	5/23/1998 2:35:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 6136

Izzzy: CIST? Gawwwwwwwd, no. My nightmare? Never, ever again will I invest in a penny stock. :-) Donna should be willing to update you, to a degree, on second generation PIs. I haven't checked for a LONG time, but they were interested in (1) something that would be as efficacious as V. but simpler to synthesize, and (2) a cheaper/easier route to a chemical intermediate for V. BTW.... that's another thing about AGPH.... I was in frequent contact with IR at the company when it was Donna, period. I talked with them frequently, and I was lucky enough to be hosted at the facilities on a couple of occasions. I never, not once, got any info that was not publically available to any other shareholder. The company simply was not leaky. However, I got a continuous feel for morale and a clear feel for the public information which was of most importance to the company's direction. I was exclusively retained by a major biotech underwriter during '96 and '97. I continuously, daily, passed my enthusiasm on to them. They didn't read the public info in the fashion that I read it, and they never initiated enthusiastic coverage, missing the biotech success story of the period. Rick